Glutathione S-transferase-π expression and glutathione concentration in ovarian carcinoma before and after chemotherapy

Cancer

Volumn 79, Issue 3, 1997, Pages 521-527

  Cheng, Xiusi ^a   Kigawa, Junzo ^a   Minagawa, Yukihisa ^a   Kanamori, Yasunobu ^a   Itamochi, Hiroaki ^a   Okada, Makoto ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

chemotherapy; drug resistance; glutathione; glutathione S transferase ; NIH image; ovarian carcinoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE TRANSFERASE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; BLOTTING, WESTERN; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; TIME FACTORS;

EID: 0031029606     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970201)79:3<521::AID-CNCR14>3.0.CO;2-5     Document Type: Article

References (39)

1. Muggia FM. Cisplatin update. Semin Oncol 1991;8:1-4.
2. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC, Anderson ME. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A 1992; 89:3070-4.
3. Kigawa J, Minagawa Y, Ishihara H, Kanamori Y, Terakawa N. Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary. Cancer 1993;72:804-8.
4. Andrews PA, Velury S, Mann SC, Howell SB. Cis-Diamminedichloroplatinum (II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res 1988;48:68-73.
5. Andrews PA, Howell SB. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cell 1990;2:35-43.
6. Fujiwara Y, Sugimoto Y, Kasahara K, Bungo M, Yamakido M, Tew KD, et al. Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn J Cancer Res 1990;81:527-35.
7. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, et al. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 1991;51:3237-42.
8. Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M, Hamilton TC. Increased DNA repair as a mechanism of acquired resistance to cis-Diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res 1988;48:5713-6.
9. Minagawa Y, Kigawa J, Ishihara H, Itamochi H, Terakawa N. Synergistic enhancement of cisplatin cytotoxicity by SN-38, an active metabolite of CPT-11, for cisplatin-resistant Hela cells. Jpn J Cancer Res 1994;85:966-71.
10. Arrick BA, Nathan CF. Glutathione metabolism as a determinant of therapeutic efficacy. Cancer Res 1984;44:4424-32.
11. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci U S A 1985;82:3964-8.
12. Sherman M, Campbell JAH, Titmuss SA, Kew MC, Kirsch RE. Glutathione S-transferase in human hepatocellular carcinoma. Hepatology 1983;3:170-6.
13. Dulik DM, Fenselau C, Hilton J. Characterization of melphalan glutathione adducts whose formation is catalyzed by glutathione transferases. Biochem Pharmacol 1986;35:3405-9.
14. Schecter RL, Alaoui-Jamali MA, Batist G. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis. Biochem Cell Biol 1992;70:349-53.
15. Green JA, Robertson LJ, Clark AH. Glutathione S-transferase expression in benign and malignant ovarian tumors. Br J Cancer 1993;68:235-9.
16. Hamada S, Kamada M, Furumoto H, Hirao T, Aono T. Expression of glutathione S-transferase-π in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecol Oncol 1994;52:313-9.
17. Mulder TPJ, Verspaget HW, Sier CFM, Roelofs HMJ, Ganesh S, Griffioen G, Peters WHM. Glutathione S-transferase-π in colorectal tumors is predictive for overall survival. Cancer Res 1995;55:2696-702.
18. Ribrag V, Massad L, Janot F, Morizet J, Gouyette A, Chabot GG. Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy. Leuk Lymphoma 1995;18:303-10.
19. Efferth T, Mattern J, Volm M. Immunohistochemical detection of P glycoprotein, glutathione S-transferase, and DNA topoisomerase II in human tumors. Oncology 1992;49:368-75.
20. Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 1993;53:5225-32.
21. Kido Y, Khokhar AR, Siddik ZH. Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells. Biochem Pharmacol 1994;47:1635-42.
22. Peters WHM, Roelofs HMJ. Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases. Cancer Res 1992;52:1886-90.
23. Britten RA, Green JA, Warenius HM. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents. Int J Radiat Oncol Biol Phys 1992;24:527-31.
24. Germain I, Tetu B, Brisson J, Mondor M, Cherian G. Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 cases. Int J Gynecol Pathol 1996; 15:54-62.
25. Murphy D, Mcgown AT, Hall A, Cattan A, Crowther D, Fox BW. Glutathione S-transferase activity and isoenzyme distribution in ovarian tumor biopsies taken before or after cytotoxic chemotherapy. Br J Cancer 1992;66:937-42.
26. Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. The relationships between glutathione, glutathione S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br J Cancer 1991; 64:215-20.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
28. Rasband W. NIH Image [computer program online]. Bethesda, MD: National Institutes of Health. Available: http://rsb.info.nih.gov/nih-image/.
29. Owens CWI, Belcher RV. A colorimetric micro-method for the determination of glutathione. Biochem J 1965;94:705-11.
30. Doroshow JH, Metz MZ, Matsumoto L, Winters KA, Sakai M, Marmots M, et al. Transduction of NIX 3T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase-π produces broad-range multidrug resistance. Cancer Res 1995;55:4073-8.
31. Lewis AD, Hayes JD, Wolf CR. Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects. Carcinogenesis 1988;9:1283-7.
32. Wang Y, Teicher BA, Shea TD, Holden SA, Rosbe KW, Alachi A, Henner WD. Cross-resistance and glutathione S-transferase-π levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res 1989; 49:6185-92.
33. Teicher BA, Holden SA, Herman TS, Sotomayor EA, Khandekar V, Rose KW, et al. Characteristics of five human tumor cell lines and sublimes resistant to cis-Damon dichloroplatinum(II). Int J Cancer 1991;47:252-60.
34. Yang LY, Trujillo JM, Siciliano MJ, Kid Y, Siddik ZH, Su YZ. Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II). Int J Cancer 1993; 53:478-85.
35. Ishikawa T, Boo JO, Yeomen Y, Akimaru K, Frindrich K, Wright CD, et al. Coordinated induction of MRP/GS-X pump and γ-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem. 1996;271: 15091-8.
36. Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 1996;56:988-4.
37. Lee FYK, Siemann DW, Sutherland RM. Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer: a possible indicator of chemosensitivity. Br J Cancer 1989;60:291-8.
38. Goddard P, Valenti M, Kelland LR. The role of glutathione (GSH) in determining sensitivity to platinum drugs in viva in platinum-sensitive and -resistant murine leukemia and plasmacytoma and human ovarian carcinoma xenografts. Anticancer Res 1994;14:1065-70.
39. Inn T, Itched T, Siege K, Myra Y, Sugimachi K. Glutathione S-transferase pi is a powerful indicator in chemotherapy of human lung squamous-cell carcinoma. Respiration 1995;62:223-7.